Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Investigation of RISE´s possibility to take over the operation of SWETOX

Reference number
Coordinator RISE Research Institutes of Sweden AB - Bioscience and Materials / Surface, Process and Formulation
Funding from Vinnova SEK 500 000
Project duration February 2018 - July 2018
Status Completed

Purpose and goal

RISE has investigated the possibility of taking over all or parts of SWETOX / ETV. The aim was to generate material (due diligence and a business plan), a plan forward and external financing of the predicted deficit of 30MSEK, the first 3 years. A supportive decision by RISE governing board has been achieved.

Expected results and effects

By delivering toxicological risk assessment of new chemicals, materials and drug candidates, RISE will contribute to the increasing need of industry for these analyses as well as the competitiveness of the Swedish life science industry, by investing in infrastructure for future needs. In addition, this will also contribute to the global goals for sustainable development.

Planned approach and implementation

A due diligence of the operations at Swetox Gärtuna has been performed. A business plan has been produced for the next 4 years ahead. The conclusion is that the operations at Swetox infrastructure could fit into RISE organization. It would complement the present offer by RISE and there are good possibilities for synergy, and it would address the growing need for toxicological risk assessments from a wide range of industrial and academic target groups.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 8 January 2019

Reference number 2018-00541

Page statistics